A phase III clinical trial has shown the cannabis-based medicine Epidiolex® (cannabidiol oral solution) to reduce seizures in children with Dravet syndrome, a rare and severe form of childhood-onset epilepsy.
Sydney Children’s Hospital, Randwick, was one of two sites in Australia to take part in the international study, which reinforced the safety and efficacy of the drug in reducing sei...
